Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
SHL Medical and MoonLake Immunotherapeutics collaborate to develop sonelokimab autoinjector 2023-05-03 22:43
EDAN Announces Integration with PointClickCare for Better Senior Primary Care 2023-05-03 21:56
Lantern Pharma Selects REPROCELL USA to Provide Support for the Phase 2 Harmonic™ Clinical Trial 2023-05-03 21:00
Skyline Therapeutics to Present at the ASGCT 26th Annual Meeting 2023-05-03 12:00
Chula Researchers Develop Rapid MTB Strip Test for Tuberculosis 2023-05-03 11:34
Merck Signs MoU with Ministry of Trade, Industry & Energy and Daejeon City for New Asia Pacific BioProcessing Production Center in South Korea 2023-05-03 10:00
Completion of Enrollment in Cohorts C and G of China Phase II Clinical Study of Osemitamab (TST001) in Combination with CAPOX with or without Nivolumab as First-line Treatment of Gastric/Gastro-esophageal Junction Cancer Patients 2023-05-03 08:00
Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis 2023-05-03 00:22
Cellenkos Announces First Patient Dosed with CK0803 Cell Therapy for Treatment of Amyotrophic Lateral Sclerosis 2023-05-03 00:07
China Jo-Jo Drugstores Receives Hangzhou Municipal People's Government Quality Management Excellence Award 2023-05-02 20:30
Ascletis Announces ASC40, a First-in-Class, Once-Daily Oral FASN Inhibitor, Achieved Endpoints in Phase II Clinical Trial for Acne 2023-05-02 17:30
First Patients in Canada Imaged with Illuccix®: Now Commercially Available Nationwide 2023-05-02 05:00
I-MAB Filed 2022 Annual Report on Form 20-F 2023-05-01 20:00
Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease 2023-05-01 18:30
ZIRCON Phase III Kidney Cancer Imaging Study Presented at AUA: New Data Confirms Efficacy in Masses 2cm or Smaller 2023-05-01 08:58
OBiO and CHINAGENE reached a strategic agreement of commercial manufacturing services for gene therapy products 2023-04-29 23:20
IMG-004 demonstrated extended half-life and durable pharmacodynamic characteristics in a Phase 1 study 2023-04-28 17:00
WuXi Biologics Releases 2022 ESG Report Detailing Its Continued Commitment to Sustainability 2023-04-28 14:43
Brii Bio Publishes 2022 Environmental, Social and Governance Report 2023-04-28 09:00
Daewoong Pharmaceutical announces a Global License Agreement for DWP213388, a new drug candidate for autoimmune disease with Vitalli Bio 2023-04-28 08:58
1 108 109 110 111 112 414